Reproductive Health

Meet the 6 Innovation Spotlight Finalists from this Week’s Fertility Innovation Summit

Egg Donor Matching Platform Tulip Closes a $1.7M Seed Round

Mayne Pharma’s Receives FDA Approval for NEXTSTELLIS, a New Oral Contraceptive Containing E4, the First New Estrogen Introduced in the U.S. in 50 Years

Twentyeight Health Launches Telehealth for Birth Control Prescriptions and Delivery in Texas

Women First Digital Launches Ally, the World’s First Abortion Virtual Assistant on WhatsApp

Natera and Tesis Labs Announce Strategic Collaboration on Prenatal Genetic Testing

WINFertility Teams Up with Akin Gump to Provide Inclusive Family-Building Benefits for All U.S. Employees

Event: Fertility Innovation Summit on April 20

Rebrand: Fertility Focus’ OvuSense Sensor Is Changing Its Name to Ovucore

Jubel Health Launches a Personal Fertility Companion App to Support Women on Their Reproductive Health and Wellness Journey

Women’s Health Telemedicine Platform Twentyeight Health Announces Its Expansion Across the Midwestern United States

Mayne Pharma Launches A Generic Version of ORTH-CEPT, an Oral Contraceptive, in the U.S.

Brian E. Miller, Ph.D. joins TMRW as SVP of Sales to Help Bring the Company’s Technology to U.S. Fertility Clinics

Unfabled: An Interview with Founder & CEO Hannah Samano about Sustainable Cycle Care and Taking An E-Commerce Startup from Zero to One in Less Than Two Months

Nurx Expands Its Service and Now Offers At-Home Acne Care

Clue Receives FDA Approval to Launch a Digital Contraceptive

Dr. Raquel Hammonds Joins Carrot Fertility as Director of Integrative and Preventative Medicine, a Newly Created Role at the Company

Women’s Health Startup Maven Launches MavenRx, a Fertility Drug Delivery Service to Further Strengthen Its Fertility Program

Online Reproductive Health Provider Simple Health Now Also Offers Supplements

ExEm Foam, the Only FDA-Approved Contrast Agent for Ultrasound Tubal Patency Testing Is Now Available in the U.S.

5-Minute Femtech Brief: Birth Control

Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health

Evofem Launches Its First DTC Advertising Campaign to Accelerate Awareness of Phexxi, Its Non-Hormonal Birth Control Option for Women

Emme’s Amanda French: “In 2019, Femtech received just under $800 million in funding. That number could be in the billions this decade.”